Meltz Mark A

CIK 00017713293 companiesSOUTH SAN FRANCISCO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001771329

Recent Transactions

22 trades

Award
Lyell Immunopharma, Inc.$LYEL
Option (right to buy)
2025-06-09+100,000→ 100,000 total
Disposition to Issuer
Kinnate Biopharma Inc.
Stock Option (right to buy)
2024-04-03−215,000→ 0 total
Disposition to Issuer
Kinnate Biopharma Inc.
Common Stock
2024-04-03−27,578→ 0 total
Disposition to Issuer
Kinnate Biopharma Inc.
Stock Option (right to buy)
2024-04-03−121,503→ 0 total
Disposition to Issuer
Kinnate Biopharma Inc.
Stock Option (right to buy)
2024-04-03−384,508→ 0 total
Disposition to Issuer
Kinnate Biopharma Inc.
Stock Option (right to buy)
2024-04-03−135,000→ 0 total
Disposition to Issuer
Kinnate Biopharma Inc.
Stock Option (right to buy)
2024-04-03−100,000→ 0 total
Tax Payment
Kinnate Biopharma Inc.
Common Stock
2024-03-01$2.59/sh−558→ 27,578 total
Tax Payment
Kinnate Biopharma Inc.
Common Stock
2023-12-01$2.25/sh−541→ 28,136 total
Tax Payment
Kinnate Biopharma Inc.
Common Stock
2023-09-01$2.35/sh−541→ 28,677 total
Tax Payment
Kinnate Biopharma Inc.
Common Stock
2023-06-01$4.30/sh−541→ 29,218 total
Tax Payment
Kinnate Biopharma Inc.
Common Stock
2023-03-01$5.21/sh−638→ 27,286 total
Award
Kinnate Biopharma Inc.
Employee Stock Option (right to buy)
2023-02-10+215,000→ 215,000 total
Tax Payment
Kinnate Biopharma Inc.
Common Stock
2022-12-01$7.75/sh−541→ 27,924 total
Award
Kinnate Biopharma Inc.
Common Stock
2022-09-01+25,000→ 28,465 total
Award
Kinnate Biopharma Inc.
Employee Stock Option (right to buy)
2022-02-11+135,000→ 135,000 total
Award
Kinnate Biopharma Inc.
Employee Stock Option (right to buy)
2021-02-12+100,000→ 100,000 total
Disposition from Tender
Audentes Therapeutics, Inc.
Common Stock
2020-01-15$60.00/sh−32,705→ 0 total
Disposition to Issuer
Audentes Therapeutics, Inc.
Stock Option (Right to Buy)
2020-01-15−104,000→ 0 total
Tax Payment
Audentes Therapeutics, Inc.
Common Stock
2019-12-12$59.37/sh−4,628→ 32,705 total
Award
Audentes Therapeutics, Inc.
Stock Option (right to buy)
2019-03-28+104,000→ 104,000 total
Award
Audentes Therapeutics, Inc.
Common Stock
2019-03-28+37,333→ 37,333 total

Companies

Recent Filings

Address

C/O LYELL IMMUNOPHARMA, INC. 201 HASKINS WAY, SUITE 101

SOUTH SAN FRANCISCO, CA, 94080

View on SEC.gov